获批不到一年，本维莫德大降价。7月21日，泽德曼医药宣布，决定将其本维莫德乳膏（商品名：泽立美）15 g/支的零售售价，从每盒980元调整至360元，降幅达63.2%。奥希替尼有新收获。7月21日，阿斯利康宣布，III期FLAURA2研究最终总生存期（OS）分析取得积极结果。在一线治疗局部晚期或转移性表皮生长因子受体突变（EGFRm）非小细胞肺癌（NSCLC）患者中，奥希替尼联合培美曲塞和铂类化疗...
Source Link获批不到一年，本维莫德大降价。7月21日，泽德曼医药宣布，决定将其本维莫德乳膏（商品名：泽立美）15 g/支的零售售价，从每盒980元调整至360元，降幅达63.2%。奥希替尼有新收获。7月21日，阿斯利康宣布，III期FLAURA2研究最终总生存期（OS）分析取得积极结果。在一线治疗局部晚期或转移性表皮生长因子受体突变（EGFRm）非小细胞肺癌（NSCLC）患者中，奥希替尼联合培美曲塞和铂类化疗...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.